These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9356941)

  • 1. Destruction of contrast microbubbles during ultrasound imaging at conventional power output.
    Villarraga HR; Foley DA; Aeschbacher BC; Klarich KW; Mulvagh SL
    J Am Soc Echocardiogr; 1997 Oct; 10(8):783-91. PubMed ID: 9356941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between microbubbles and ultrasound: in vitro and in vivo observations.
    Wei K; Skyba DM; Firschke C; Jayaweera AR; Lindner JR; Kaul S
    J Am Coll Cardiol; 1997 Apr; 29(5):1081-8. PubMed ID: 9120163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing susceptibility of echocardiographic contrast agents to adverse effects of biologic factors: multicenter, videodensitometric comparison of octafluoropropane-filled microspheres with air-filled microspheres for left ventricular opacification.
    Hausnerova E; Gottdiener JS; Gould JJ; Pezzullo JC; Callahan JD; Cohen JL; Bruns DE; Kuvelas MT; West HE; Dittrich HC
    J Am Soc Echocardiogr; 1999 Nov; 12(11):957-66. PubMed ID: 10552357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of oxygen inhalation on myocardial opacification using levovist: an animal experimental study].
    Kashiwagi Y; Beppu S; Ishikura F; Ueda H; Yagura S; Kayano H
    J Cardiol; 2001 Jun; 37(6):335-40. PubMed ID: 11433809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
    Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
    J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial contrast enhancement after intravenous injection of sonicated albumin microbubbles: a transesophageal echocardiography dipyridamole study.
    Voci P; Bilotta F; Merialdo P; Agati L
    J Am Soc Echocardiogr; 1994; 7(4):337-46. PubMed ID: 7917341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of reducing the cardiac cycle-triggering frequency of ultrasound imaging to increase myocardial opacification with FSO69 during fundamental and second harmonic imaging.
    Colon PJ; Richards DR; Moreno CA; Murgo JP; Cheirif J
    J Am Soc Echocardiogr; 1997; 10(6):602-7. PubMed ID: 9282349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial contrast echocardiography for assessment of myocardial perfusion at rest in a patient with left main coronary artery stenosis.
    Hagendorff A; Pfeiffer D; Rother T; Becher H
    Z Kardiol; 2003 Oct; 92(10):876-83. PubMed ID: 14579053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of static pressure on the disappearance rate of specific echocardiographic contrast agents.
    Vuille C; Nidorf M; Morrissey RL; Newell JB; Weyman AE; Picard MH
    J Am Soc Echocardiogr; 1994; 7(4):347-54. PubMed ID: 7917342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct video-microscopic observation of the dynamic effects of medical ultrasound on ultrasound contrast microspheres.
    Klibanov AL; Ferrara KW; Hughes MS; Wible JH; Wojdyla JK; Dayton PA; Morgan KE; Brandenburger GH
    Invest Radiol; 1998 Dec; 33(12):863-70. PubMed ID: 9851820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization of risk-area myocardium as a high-intensity, hyperenhanced "hot spot" by myocardial contrast echocardiography following coronary reperfusion: quantitative analysis.
    Kunichika H; Peters B; Cotter B; Masugata H; Kunichika N; Wolf PL; DeMaria AN
    J Am Coll Cardiol; 2003 Aug; 42(3):552-7. PubMed ID: 12906988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of right ventricular myocardial opacification by contrast echocardiography and comparison with left ventricular intensity.
    Masugata H; Cotter B; Ohmori K; Kwan OL; Mizushige K; DeMaria AN
    Am J Cardiol; 1999 Nov; 84(9):1137-40, A11. PubMed ID: 10569688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimal setting of focus points for myocardial contrast echocardiography with intravenous Optison (FS-69): an experimental study].
    Daimon M; Beppu S; Ishikura F; Ueda H; Kobayashi H; Kashiwagi Y; Yagura S; Yoshikawa J
    J Cardiol; 2001 Apr; 37(4):201-7. PubMed ID: 11337929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrected quantification method to determine myocardial blood flow using real-time myocardial contrast echocardiography.
    Otani K; Masuda K; Asanuma T; Ishikura F; Beppu S
    J Am Soc Echocardiogr; 2006 Aug; 19(8):973-81. PubMed ID: 16880091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial ultrasound contrast that correlates with coronary blood flow.
    Porter TR; Xie F; Kilzer K
    J Am Soc Echocardiogr; 1995; 8(5 Pt 1):710-8. PubMed ID: 9417215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial cavitational activity during continuous infusion and bolus intravenous injections of perfluorocarbon-containing microbubbles.
    Porter TR; Everbach C; Kricsfeld D; Xie F
    J Am Soc Echocardiogr; 2001 Jun; 14(6):618-25. PubMed ID: 11391291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial contrast echocardiography: reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent.
    Meza M; Greener Y; Hunt R; Perry B; Revall S; Barbee W; Murgo JP; Cheirif J
    Am Heart J; 1996 Oct; 132(4):871-81. PubMed ID: 8831379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of QW7437, a new fluorocarbon-based echocardiographic contrast agent.
    Main ML; Escobar JF; Hall SA; Grayburn PA
    J Am Soc Echocardiogr; 1997 Oct; 10(8):798-804. PubMed ID: 9356943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonic characterization of the nonlinear properties of contrast microbubbles.
    Shi WT; Forsberg F
    Ultrasound Med Biol; 2000 Jan; 26(1):93-104. PubMed ID: 10687797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.